In recent years, as the first or corresponding author, Prof. Li has published more than twenty representative papers in prestigious journals such as Nature Nanotechnology, Nature Reviews Bioengineering, Nature Communications, Science Advances, Med, Cell Biomaterials, Trends in Pharmacological Sciences (Cell Press), PNAS, Chemical Society Reviews, Advanced Materials, Advanced Functional Materials, Advanced Drug Delivery Reviews, Journal of Controlled Release, etc. Our research has been cited and introduced by Nature Reviews Drug Discovery, Nature Immunology, Nature Cancer, Nature Reviews Materials, Cancer Cell, Chemical Reviews, Chemical Society Reviews etc., and featured in Nature Communications Editors' Highlights.

Publications in CUHK-Shenzhen (*corresponding author; # equal contribution)

19. Zhu et al., in preparation, 2026

18. Sun et al., in preparation, 2026.

17. Li et al., in preparation, 2026.

16. Yang et al., under review, 2026.

15. Zhou et al., in revision, 2026.

14. Li et al., in revision, 2026.

13. Yang et al., in revision, 2026.

12. Yin et al., in revision, 2026.

11. Li et al., in revision, 2026.

10. Li et al., revised, 2026.

9. Jie Yu, Shuhua Yin, Jiong Li, Yilin Zhang, Xiuli Zhong, Nuo Zhou, Wei Li, Yixin Wang*, Renke Li*, Minjie Sun*, Zhaoting Li*, Med (Cell Press), 7, 101261, 2026, https://doi.org/10.1016/j.medj.2026.101261.

8. Khan Haroon, Jie Yu, Renke Li*, Chuancheng Ren*, Zhaoting Li*, Harnessing extracellular vesicles for ischemic stroke management, Regenerative Biomaterials, rbag038, https://doi.org/10.1093/rb/rbag0382026.

7. Wanlin Ye, Xin Li, Jocelyn Chandra, Jie Yu, Tuoyu Zhou, Zhaoting Li*, Targeting metabolic vulnerabilities with advanced delivery systems, Trends in Pharmacological Sciences (Cell Press), Volume 47, Issue 3, 309-324, 2026. (Invited, Selected as the Cover)

6. Qiang Li, Yinan Ding, Yejiao Shi, Chong Qiu, Lei Lei, Shenglong Li, Zheng Zhu, Judun Zheng,Cheng Qin, Kaiyuan Wang, Cheng Jiang, Ziyi Han, Lingyan Yang, Lang Zhang, Ping Li, Lingjun Tong, Duan Wang, Hong Xu, Bingyang Dai, Yangyang Du, Kaiyang Wang, Zhijin

Fan, Wei Wang, Keying Guo, Yu Huang, Xia Wang,Bingdong Sui, Liang Wen, Feixiong Chen,

Dechao Feng, Xiang Qin, Wenjun Mao, Hongxing Liu, Chen Liu, Zhaoting Li, Yongfei Wang, Ru Huang, Rong Lu, Yulin Zhang, Ying Tian, Xiaolong Miao, Yuan Yin, Jun Zhang, Zhizeng Wang, Teng Ma, Haifeng Dong, Daixu Wei, Zhengyang Yang, Xiaohong Yang, Xiaoyu Cheng, Wojciech Chrzanowski, Zhigang Chang, Xudong Zhang, William C. Cho, Yang Luo, Weiliang Xia, Zhaohui Huang, 80 years of extracellular vesicles: from discovery to

clinical translation, Extracellular Vesicles and Circulating Nucleic Acids, 7:165-233, 2026.

5. Nuo Zhou, Jocelyn Chandra, Hanxiang Zhu, Jie Yu, Wanlin Ye, Renke Li*, Zhaoting Li*, Engineered cells for cardiovascular diseases, Cell Biomaterials 2, 100280, May 19, 2026.

4. Zhaoting Li, Yixin Wang, Fanyi Mo, Tyler Wolter, Rachel Hong, Allie Barrett, Nathaniel Richmond, Fengyuan Liu, Yu Chen, Xicheng Yang, Lauren Dempsey, Quanyin Hu*, Engineering pyroptotic vesicles as personalized cancer vaccines, Nature Nanotechnology, volume 20, pages1108–1118 (2025), https://doi.org/10.1038/s41565-025-01931-2.

3. Jingyuan Wu#, Wanlin Ye#, Jie Yu, Tuoyu Zhou, Nuo Zhou, Dennis K. P. Ng, Zhaoting Li*, Engineered bacteria and bacterial derivatives as advanced therapeutics for inflammatory bowel disease, Essays in Biochemistry (Invited), 2025 Feb 27;69(2).

2. Zhaoting Li, Yixin Wang, Zhen Gu*, Quanyin Hu*, Engineering cells for therapy

and diagnosis, Nature Reviews Bioengineering, 2, 770-784, 2024.

1. Zhaoting Li, Fanyi Mo, Kai Guo, Shuai Ren, Yixin Wang, Yu Chen, Patrick B. Schwartz, Nathaniel Richmond, Fengyuan Liu, Sean M. Ronnekleiv-Kelly, Quanyin Hu*, Nanodrug-bacteria conjugates-mediated oncogenic collagen depletion enhances immune checkpoint blockade therapy against pancreatic cancer, Med (Cell Press), 5(4): 348-367, 2024.

Representative Publications Prior to CUHK-Shenzhen

1. Zhaoting Li, Fanyi Mo, Yixin Wang, Wen Li, Yu Chen, Jun Liu, Ting-Jing Chen-Mayfield, Quanyin Hu, Enhancing Gasdermin-Induced Tumor Pyroptosis Through Preventing ESCRT-Dependent Cell Membrane Repair Augments Anti-Tumor Immune Response, Nature Communications, 13, 6321, 2022.

2. Zhaoting Li, Yingyue Ding, Jun Liu, Jianxin Wang, Fanyi Mo, Yixin Wang, Ting-Jing Chen-Mayfield, Paul M. Sondel, Seungpyo Hong, Quanyin Hu, Depletion of tumor associated macrophages enhances local and systemic platelet-mediated anti-PD-1 delivery for post-surgery tumor recurrence treatment, Nature Communications, 13, 1845, 2022.

3. Zhaoting Li, Lianghan Zhu, Honghao Sun, Yuexin Shen, Dandan Hu, Wenhao Wu, Yixin Wang, Chenggen Qian, Minjie Sun, Fluorine assembly nanocluster breaks the shackles of immunosuppression to turn the cold tumor hot, PNAS, vol. 117 no. 49, 2020.

4. Zhaoting Li, Yixin Wang, Yuexin Shen, Chenggen Qian, David Oupicky, Minjie Sun, Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti-PD-L1 immunotherapy, Science Advances, eaaz9240, 2020.

5. Zhaoting Li, Yixin Wang, Jun Liu, Piper Rawding, Jiyoon Bu, Seungpyo Hong, Quanyin Hu, Chemically and Biologically Engineered Bacteria-Based Delivery Systems for Emerging Diagnosis and Advanced Therapy, Advanced Materials, 33(38), e2102580, 2021.